| Identification | Back Directory | [Name]
Mycobactin s | [CAS]
26769-11-9 | [Synonyms]
Mycobactin s
L-Lysine, N2-((4,5-dihydro-2-(2-hydroxyphenyl)-4-oxazolyl)carbonyl)-N6-hydroxy-N6-(1-oxo-2-octadecenyl)-, 3-((hexahydro-1-hydroxy-2-oxo-1H-azepin-3-yl)amino)-1-methyl-3-oxopropyl ester, stereoisomer
L-Lysine, N2-[[(4S)-4,5-dihydro-2-(2-hydroxyphenyl)-4-oxazolyl]carbonyl]-N6-hydroxy-N6-[(2Z)-1-oxo-2-octadecen-1-yl]-, (1S)-3-[[(3S)-hexahydro-1-hydroxy-2-oxo-1H-azepin-3-yl]amino]-1-methyl-3-oxopropyl ester | [Molecular Formula]
C44H69N5O10 | [MOL File]
26769-11-9.mol | [Molecular Weight]
828.05 |
| Hazard Information | Back Directory | [Description]
Mycobactin S is made from metabolic products of the acid- resistant form of Mycobacterium phlei, a tuberculosis bacillus derived originally from the cold-blooded sea turtle. Importantly, it is not based on cell wall fragments or killed bacteria. Non-pathogenic to humans, this medication modulates the immune response and is highly effective against all types of tuberculosis including lung, skeletal, bone, skin and other tissues. | [Definition]
ChEBI: Mycobactin S is a depsipeptide. |
|
|